G‐quadruplex‐binding small molecules ameliorate <i>C9orf72</i> <scp>FTD</scp> / <scp>ALS</scp> pathology <i>in vitro</i> and <i>in vivo</i>
2017 · EMBO Molecular Medicine · 212 citations
https://doi.org/10.15252/emmm.201707850
N
Nathaniel S. Woodling
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
2.0K
Citations
20
h-index
25
i10-index
Nathaniel S. Woodling is an academic researcher from University College London. The author has contributed to research in topics: Alzheimer's disease research and treatments & Genetics, Aging, and Longevity in Model Organisms & Neuroinflammation and Neurodegeneration Mechanisms. The author has an h-index of 20, co-authored 42 publications.
ORCID: 0000-0002-0298-3800Papers by this author
worksCyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice
2016 · Brain · 105 citations
https://doi.org/10.1093/brain/aww117
Microarray analysis of the in vivo response of microglia to Aβ peptides in mice with conditional deletion of the prostaglandin EP2 receptor
2015 · Genomics Data · 7 citations
https://doi.org/10.1016/j.gdata.2015.06.011
Differential neuronal vulnerability to C9orf72 repeat expansion driven by Xbp1-induced endoplasmic reticulum-associated degradation
2025 · Cell Reports · 3 citations
https://doi.org/10.1016/j.celrep.2025.115459
Initial Survey Raw Data.xlsx
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.20357871
ARUK Pilot Mentoring Scheme Survey Analyses.xlsx
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.20357877
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat